| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 3.8k | $20.85 | $78.2k | | 06/08/2023 |
| 06/08/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Exercise | Stock Option (Right to Buy) | 3.8k | $8.04 | $30.2k | | 06/08/2023 |
| 06/01/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 2.2k | $18.31 | $41.1k | | 06/01/2023 |
| 06/01/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Exercise | Stock Option (Right to Buy) | 1.9k | $6.49 | $12.2k | | 06/01/2023 |
| 02/10/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Grant | Stock Option (Right to Buy) | 50k | $20.24 | $1M | | 02/10/2023 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 400 | $21.52 | $8.6k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 975 | $22.71 | $22.1k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 400 | $23.25 | $9.3k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 100 | $24.49 | $2.4k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 1000 | $21.78 | $21.8k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 2.4k | $22.93 | $56.2k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 200 | $23.44 | $4.7k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Sale | Common Stock | 375 | $24.35 | $9.1k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Exercise | Stock Option (Right to Buy) | 1.9k | $6.49 | $12.2k | | 12/01/2022 |
| 12/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Exercise | Stock Option (Right to Buy) | 3.8k | $8.04 | $30.2k | | 12/01/2022 |
| 09/01/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Grant | Stock Option (Right to Buy) | 60k | $8.04 | $482.4k | | 09/01/2022 |
| 06/18/2022 | 4D Molecular Therapeutics, Inc. | FDMT | Grant | Stock Option (Right to Buy) | 24k | $6.49 | $155.8k | | 06/18/2022 |